Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study

por Kamei, Tadashi, Nakamura, Hiroyuki, Nanki, Nobuki, Minakata, Yoshiaki, Matsunaga, Kazuto, Mori, Yoshihiro
Publicado 2019

Randomised trial of the P2X(3) receptor antagonist sivopixant for refractory chronic cough

por Niimi, Akio, Saito, Junpei, Kamei, Tadashi, Shinkai, Masaharu, Ishihara, Hiroyuki, Machida, Mitsuaki, Miyazaki, Sayaka
Publicado 2022

Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial

por Maspero, Jorge, Agache, Ioana Octavia, Kamei, Tadashi, Yoshida, Makoto, Boone, Bryan, Felser, James M., Kawakami, Fernando, Knorr, Barbara, Lawrence, David, Lehmann, Thomas, Wang, Wei, Pedinoff, Andrew J.
Publicado 2021